|
Number of cases with adverse events after norepinephrine (NE) and placebo injections |
||||||
| Fibromyalgia |
Rheumatoid Arthritis |
Healthy Controls |
||||
|
|
|
|
||||
| (n = 20) |
(n = 20) |
(n = 20) |
||||
|
|
||||||
| placebo |
NE |
placebo |
NE |
placebo |
NE |
|
|
|
||||||
| Spreading of pain |
0 |
8 |
0 |
0 |
0 |
0 |
| Pale halo |
0 |
3 |
0 |
1 |
0 |
1 |
| Paresthesias |
5 |
2 |
4 |
3 |
5 |
2 |
| Palpitations |
0 |
1 |
0 |
0 |
0 |
0 |
| Sweating |
0 |
1 |
0 |
0 |
0 |
0 |
| Distal swelling |
0 |
1 |
0 |
0 |
0 |
0 |
Martinez-Lavin et al. BMC Musculoskeletal Disorders 2002 3:2 doi:10.1186/1471-2474-3-2 |
||||||